2023
DOI: 10.1002/tox.23951
|View full text |Cite
|
Sign up to set email alerts
|

The neddylation inhibitor MLN4924 inhibits proliferation and triggers apoptosis of oral cancer cells but not for normal cells

Yan‐Ning Chen,
Yu‐Hsuan Chan,
Jun‐Ping Shiau
et al.

Abstract: Increased neddylation benefits the survival of several types of cancer cells. The inhibition of neddylation has the potential to exert anticancer effects but is rarely assessed in oral cancer cells. This study aimed to investigate the antiproliferation potential of a neddylation inhibitor MLN4924 (pevonedistat) for oral cancer cells. MLN4924 inhibited the cell viability of oral cancer cells more than that of normal oral cells (HGF‐1) with 100% viability, that is, IC50 values of oral cancer cells (CAL 27, OC‐2,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 67 publications
0
1
0
Order By: Relevance
“…Two oral cancer cell lines were applied in this study, namely HSC-3 (JCR Bank, Ibaraki, Osaka, Japan) and OC-2 [ 63 ] (kindly given by Kaohsiung Medical University (Dr. Wan-Chi Tsai)). The cultural maintenance and medium preparation have been described previously [ 64 ]. Cell viability was evaluated with a CCK-8 reagent (IMT Formosa New Materials, Kaohsiung, Taiwan) [ 65 ] for 1 h.…”
Section: Methodsmentioning
confidence: 99%
“…Two oral cancer cell lines were applied in this study, namely HSC-3 (JCR Bank, Ibaraki, Osaka, Japan) and OC-2 [ 63 ] (kindly given by Kaohsiung Medical University (Dr. Wan-Chi Tsai)). The cultural maintenance and medium preparation have been described previously [ 64 ]. Cell viability was evaluated with a CCK-8 reagent (IMT Formosa New Materials, Kaohsiung, Taiwan) [ 65 ] for 1 h.…”
Section: Methodsmentioning
confidence: 99%
“…TRAIL-resistant cancer cells have hyperactive survival signaling. Different natural and synthetic molecules have been tested to increase the sensitivity of cancer cells to TRAIL-based therapeutics (80)(81)(82)(83)(84).…”
Section: Trail-based Therapeutics Mediated Pyroptosismentioning
confidence: 99%